Equitec Proprietary Markets’s Alpha Tau Medical Warrant DRTSW Stock Holding History

Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake
Trade Value Portfolio Weight Portfolio Position
2026
Q2
$5.61K Hold
1,900
﹤0.01% 78
2026
Q1
$1.9K Hold
1,900
﹤0.01% 66
2025
Q4
$646 Hold
1,900
﹤0.01% 77
2025
Q3
$656 Hold
1,900
﹤0.01% 72
2025
Q2
$418 Hold
1,900
﹤0.01% 62
2025
Q1
$451 Hold
1,900
﹤0.01% 60
2024
Q4
$399 Hold
1,900
﹤0.01% 53
2024
Q3
$361 Hold
1,900
﹤0.01% 62
2024
Q2
$385 Hold
1,900
﹤0.01% 65
2024
Q1
$475 Hold
1,900
﹤0.01% 79
2023
Q4
$366 Sell
1,900
-9,676
-84% -$2.34K ﹤0.01% 93
2023
Q3
$2.92K Sell
11,576
-4,624
-29% -$1.49K ﹤0.01% 96
2023
Q2
$6.4K Sell
16,200
-10,700
-40% -$3.27K ﹤0.01% 79
2023
Q1
$7.53K Sell
26,900
-10,000
-27% -$3.79K ﹤0.01% 94
2022
Q4
$9.23K Hold
36,900
﹤0.01% 135
2022
Q3
$16K Hold
36,900
﹤0.01% 169
2022
Q2
$18K Sell
36,900
-200
-0.5% -$111 0.01% 167
2022
Q1
$23K Buy
+37,100
New +$20.2K 0.01% 139

Other funds holding DRTSW

Equitec Proprietary Markets's DRTSW Position: Q2 2026 in Review

Equitec Proprietary Markets held its Alpha Tau Medical Warrant (DRTSW) position steady in Q2 2026 at 1,900 shares worth $5.61K. The position accounts for ﹤0.01% of the portfolio, ranked #78.

Equitec Proprietary Markets first reported a position in DRTSW in Q1 2022 and has held it in 18 quarters since. The position peaked at $23K in Q1 2022. 2 funds tracked by Wall St. Rank hold DRTSW as of Q2 2026.

  • Equitec Proprietary Markets held 1,900 shares of Alpha Tau Medical Warrant worth $5.61K as of Q2 2026.
  • Equitec Proprietary Markets left its Alpha Tau Medical Warrant share count unchanged in Q2 2026.
  • Alpha Tau Medical Warrant made up ﹤0.01% of Equitec Proprietary Markets's portfolio in Q2 2026, its #78 holding.
  • Equitec Proprietary Markets first reported a position in Alpha Tau Medical Warrant in Q1 2022 and has held it in 18 quarters since.
  • Equitec Proprietary Markets's Alpha Tau Medical Warrant position peaked at $23K in Q1 2022.
  • 2 funds tracked by Wall St. Rank held Alpha Tau Medical Warrant as of Q2 2026.

Based on Equitec Proprietary Markets's 13F filing for Q2 2026, filed 20 Jul 2026.